Enzymatic Therapy's CompleteGest®(1) Renew Targets Special Digestive Issues

As people age, changes in the digestive tract make occasional digestive issues more likely. In fact, nearly 70 million Americans have some sort of digestive issue every year, and as many as 40% of older, boomer-aged adults have one or more symptoms related to digestive concerns. Enzymatic Therapy(R) has launched the answer for baby boomers wondering what happened to their digestive systems -- CompleteGest(1) Renew age-optimized enzymes.

Most boomers remember when they could eat whatever they wanted without worrying about suffering any discomfort. There's a biological reason they can't enjoy foods the way they used to. According to Cheryl Myers, Vice President of Health Sciences at Enzymatic Therapy, "As the body ages, enzyme production is dramatically reduced, so you aren't able to break down foods as effectively as you once could. This leaves people with occasional gas, discomfort and bloating after enjoying some of their favorite foods."

CompleteGest(1) Renew is a new, proprietary formula that goes above and beyond other digestion products on the market. It's custom-formulated to meet the needs of people past their thirties, and designed to enhance the ability to digest problematic foods including raw foods, fats, wheat and dairy.(1) This breakthrough product helps the boomer generation say good-bye to occasional digestive discomfort and rediscover the pleasure of eating -- at any age!(1)

CompleteGest(1) Renew is the newest addition to Enzymatic Therapy's successful line of enzyme products, and is available at natural food retailers nationwide.

For nearly 30 years, Enzymatic Therapy, Inc., (ETI) based in Green Bay, Wisconsin, has been North America's leading manufacturer and distributor of dietary supplements and natural medicines. ETI is an FDA-registered drug establishment and also a certified organic processor. It was the first company to introduce standardized Ginkgo biloba, glucosamine sulfate and botanical standardization to the United States health market. The company's products and ingredients are collectively the subject of over 2,500 independent, peer-reviewed-published clinical trials and studies. For more information, visit enzy.com.

(1)These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.